Home HaiXinYu Unveils Million-Square-Meter Biopharma Cluster at 2025 CSGCT Conference

HaiXinYu Unveils Million-Square-Meter Biopharma Cluster at 2025 CSGCT Conference

Sep 08, 2025 15:35 CST Updated 15:38

When frontier explorations in cell and gene therapy meet the industrial empowerment of urban renewal, an in-depth dialogue on the future of pharmaceuticals and healthcare is about to take place atCSGCT Congress, September 12-13The curtain rises. As a sponsor of this conference,Haixin Domain Urban Renewal GroupWill make a high-profile appearance with its pharmaceutical and healthcare industry cluster, leveraging space as the foundation and ecosystem as the wings to create a “fertile ground for full-chain growth” for innovative forces in the global pharmaceutical and healthcare sector.


头图.jpg


Haixin Yu: Empowering High-Quality Industrial Growth with the Power of Urban Renewal



Haixin Yu Urban Renewal Group was established in 2022. It is a first-tier supervised enterprise under the Haidian District-owned state-owned enterprise Haiguotou Group, with a registered capital of RMB 2.3 billion and an asset management area reaching2.65 million square metersWe are not merely “space transformers,” but also “industrial ecosystem builders.” Through our five-dimensional, integrated business system encompassing investment expansion, urban renewal and redevelopment, industrial operations, asset management, and smart technology, we transform old factories, idle land, and underutilized buildings into high-quality spaces that “meet industrial needs and support innovative aspirations,” thereby injecting new vitality into the development of the technology industry.

1.png


Adhering to the “equal emphasis on light and heavy assets, dual-wheel drive” model, we have established the Haixing Technology Service System, providing full-lifecycle solutions that range from incubation support in the start-up phase, to R&D space provision during the growth phase, and pilot production facilities in the maturity phase. Currently, along the Beiqing Road axis in Haidian District, we have built a pharmaceutical and health industry cluster centered on the “Zhongguancun (Haidian) Bio-Manufacturing Industrial Park (Zone A/Zone B) + Haixing Pharmaceutical Health Innovation Park Zone C + Zhongguancun Science City International Medical Valley,” which is projected to form approximatelyNearly one million square metersindustrial space that covers the entire chain of “incubation, R&D, office operations, pilot-scale testing, and production,” creating an industrial home for accelerated growth for companies in the fields of cell and gene therapy, innovative drugs, high-end medical devices, and smart healthcare.


2.png


A Tour of Industrial Clusters: Three Major Parks, Each Showcasing Its Strengths in Synergistic Coexistence




Zhongguancun (Haidian) Bio-Intelligent Manufacturing Industrial Park:

Mature Operations, Prominent Agglomeration Effects

图片


As a “Zhongguancun Featured Industrial Park,” the Bio-Manufacturing Industrial Park is divided into Zones A and B, with a total gross floor area of 120,000 square meters. In synergy with Zone C of the Haixing Pharmaceutical and Health Innovation Park, it has established a complete ecosystem spanning “incubation office space–R&D laboratories–pilot-scale production.”


Zone A (Operational): A 58,000-square-meter R&D hub featuring 6.4-meter floor-to-ceiling heights suitable for laboratory construction, with flexible spaces ranging from 1,200 to 4,300 square meters. It has attracted more than 20 cutting-edge enterprises, including United Imaging Healthcare, DTI Pharma, Yuan Yin Biotechnology, Weijiexin Biotechnology, and Zhidao Biotechnology. Comprehensive amenities such as a cafeteria, shuttle buses connecting to the subway, and sports facilities are available. Regularly held industry salons and technical exchange events foster continuous collision of innovative ideas.


3.png


Zone B (Opening in July 2025): 60,000 square meters of pilot-scale production facilities on M4-designated industrial land, comprising two standalone buildings and three semi-detached pilot plants, complemented by one service support building. With ceiling heights of up to 6 meters and a floor load capacity of 1 ton, the spaces range from 5,000 to 9,400 square meters and can be divided or combined as needed. Each building is equipped with an independent freight system, providing “tailor-made” site support for corporate pilot production. The expansive sunken courtyards allow natural light to flood the B1 level.Shops, cafes, convenience stores, and other amenities enable work and life to coexist harmoniously here.


4.png



Starfish Medical Health Innovation Park, Zone C:

Green Incubation, Ideal for Business and Innovation

图片


A 17,000-square-meter complex of Chinese-style classical architecture nestled within a landscape boasting over 60% green coverage—this is the medical and health industrial park with the highest green ratio in Haidian District, and the “place where dreams begin” for startups. With flexible office spaces ranging from 100 to 4,000 square meters, complemented by talent apartments, shared conference halls (capable of hosting forums for up to 300 attendees), and subway shuttle services, the park has already attracted more than 40 enterprises, including Bolmai, Daqing Biology, and Synbio Tech. Here, blue-gray bricks and tiles meet cutting-edge technology, adding a touch of elegance and composure to innovation.

5.png



Zhongguancun Science City International Medical Valley:

A Promising Future: Building a Global Industrial Hub

图片


Spanning 95.3 hectares with a total gross floor area of 807,000 square meters and designated as M4 industrial land, the International Medical Valley of Zhongguancun Science City serves as Haixinyu’s “future growth pole” for its strategic layout in the pharmaceutical and health industries. Focusing on three major directions—innovative drugs, high-end medical devices, and smart healthcare—it prioritizes the development of 20 niche sectors, including cell and gene therapy, AI-driven drug discovery, and surgical robots. The project plans five functional zones: Innovative Drug Incubation and Acceleration, Innovative Drug Production, Medical Device Incubation and Acceleration, Medical Device Production, and Future Frontiers, aiming to facilitate the commercialization of biomedical achievements across China.

6.png


The project is being developed in two phases, with Phase I already underway and scheduled for delivery by the end of 2026. Featuring core production facilities with ceiling heights of 6 meters or more and eight comprehensive supporting services, the project will provide enterprises with “one-stop” support spanning from R&D to production. Even more promising is the integrated “One Town, One Park” planning framework in the surrounding area, which includes two blocks of rental talent apartments, a large-scale commercial center, a K-12 school affiliated with Beijing National Day School, and a community health service center. These amenities will achieve a balance between work and living, ensuring that talent can be both attracted and retained.


Beyond Space: Full-Dimensional Services to Safeguard Every Step of Your Enterprise’s Growth



In Haixin Domain’s industrial parks, “service” is never just a slogan, but rather tangible support that provides aid in times of need and adds value to existing strengths.


Precision Policy Support: We have established a corporate policy information database to provide real-time updates on national, municipal, and district-level policies, offering “one-on-one” policy matching and interpretation for enterprises. By leveraging the RMB 20 billion Science City Fund and social capital, we have assisted five companies in securing credit loans, supported VJX Bio in completing its New Drug Application (NDA) submission, and facilitated the commercialization of 12 technological achievements for companies such as United Imaging.

7.png


Human-Centric Services: “Warmth by Your Side”: With over 30 industry events held annually, ranging from entrepreneur networking sessions and technology roadshows to fun sports games and Friday Concerts, the park is more than just a workplace—it is a “caring industrial community.” Currently, customer satisfaction among park enterprises exceeds 95%, and this recognition serves as our driving force for continuous progress.


On September 12–13, at the site of the 2nd CSGCT Conference 2025, Haixinyu’s booth will serve as a “bridge” for exchange and collaboration in the pharmaceutical and healthcare sectors. We look forward to meeting face-to-face with entrepreneurs, scientists, and investors to shareNearly one million square metersUnlocking the Infinite Potential of Industrial Clusters: Charting the Future Blueprint for Cell and Gene Therapy.


Whether you are seeking the “first stop” for R&D incubation, the “acceleration zone” for pilot-scale production, or a “habitat” within a full-chain ecosystem, Haixinyu has prepared a comprehensive “combo” of space, policies, capital, and services. Partner with Haixinyu to help pharmaceutical innovations take root and enable industrial dreams to flourish!

CSGCT Congress, see you there!


Haixin Domain Contact: Mr./Ms. Liu

8.png


2025 CSGCT Conference





主图中文版.jpg


To drive technological breakthroughs, industrial integration, policy alignment, and international cooperation in China’s cell and gene therapy (CGT) sector, and to propel the Chinese CGT industry to the forefront of global competition, the China Society for Cell and Gene Therapy (CSGCT) Conference was established.


Leveraging its close ties with the American Society of Gene & Cell Therapy (ASGCT), the 2025 CSGCT Annual Meeting will bring together leading scientists, clinical experts, multinational pharmaceutical companies, and overseas investment institutions from around the world. The event will showcase the most cutting-edge scientific advances, technologies, and applications in the global cell and gene therapy field, provide insights on market access, highlight high-quality collaborative projects, and facilitate matchmaking between overseas investors and investment opportunities. It aims to build a platform for in-depth exchange and cooperation between China’s cell and gene therapy industry and the global value chain.


This conference closely aligns with the industry's hotspots, pain points, and bottlenecks, featuring1 Main Forum + 15 High-End Sub-Forums, covering the latest advances in global gene therapy, immune cell therapy, in vivo CAR-T, adult stem cells and exosomes, iPSC-derived cell therapies, small nucleic acid drugs, gene editing, oncolytic viruses, tumor vaccines, and other fields, as well as clinical applications and breakthroughs, CMC and testing, AI-driven drug R&D, registration and regulation, investment and financing, and BD matchmaking.Comprehensive Coverage Across the Entire Industry Chain.


2025 2nd China Society for Gene and Cell Therapy (CSGCT) Congress

September 12–13, 2025

Zhongguancun National Independent Innovation Demonstration Zone Exhibition and Trading Center [Conference Center]


For more details, scan the QR code to visit the official conference website.

【配图】2025CSGCT 中国细胞与基因治疗大会_01(1).png
图片

Special Reminder

The 2025 Second China Society for Gene and Cell Therapy (CSGCT) Congress specially curated“2025 CSGCT Conference Project Pitch” Session, bringing together 1,000+ high-quality domestic and international investment institutions, industrial investors, and decision-makers from government industrial guidance funds; attracting MNCs as well as renowned domestic and international medical and pharmaceutical companies seeking business development (BD) collaborations with outstanding projects, products, and technologies; and accelerating the exchange and cooperation on the most distinctive new technologies, products, and ecosystems in China’s cell and gene therapy (CGT) sector.


路演报名.png



Conference Forum Details


排期表 0902.png